The likelihood of EGFR-positive lung cancer returning is largely tied to how advanced it is when first diagnosed, with lower chances in early stages and higher odds in later stages. Newer targeted ...

Our scalable NLP system enabled us to generate real-world insights into NSCLC recurrences, paving the way for predictive models for preventing, diagnosing, and treating NSCLC recurrence. Our NLP ...

At 36 months, the disease-free survival and molecular residual disease event-free rate was 86 vs 36% for patients in the osimertinib and placebo groups. HealthDay News — For patients with resected ...

Medically reviewed by Doru Paul, MD Key Takeaways Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype.Stage 3a lung cancer is often treated with surgery and ...

An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment of recurrent lung cancer, according to new research ...

Amini: As a radiation oncologist, I do play a larger role than I feel we used to as our patients are living longer and cure rates are improving. We are no longer just seeing the short or subacute ...

Lung cancer used to have grim outcomes but earlier detection is improving those odds. A new combined procedure with diagnosis ...